Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A

Author: Basmadjian Christine   Thuaud Frédéric   Ribeiro Nigel   Désaubry Laurent  

Publisher: Future Science

ISSN: 1756-8927

Source: Future Medicinal Chemistry, Vol.5, Iss.18, 2013-12, pp. : 2185-2197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract